Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis
布鲁金沙(Zanubrutinib)是复发或难治性慢性淋巴细胞白血病中更安全的布鲁顿酪氨酸激酶(BTK)抑制剂吗?一项系统评价和荟萃分析
期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph19030467
Hetta, Helal F; Salama, Ayman; Aljuaid, Turki A; Mojmami, Yazan T; Alotibi, Riyadh S; Alqabaly, Ahmed M; Aldosari, Nawaf A; Alshahri, Sami A; Asiri, Walid I A; Alamri, Raed S; Alanazi, Fayez A; Alenazi, Malek S A; Albuhayri, Mohammed H; Ramadan, Yasmin N; Sayad, Reem